Navigation Links
Study involving more than 100 scientists provides new insights on green algae
Date:10/11/2007

chant said. "It has to swim, find food, do photosynthesis and respiration, and it mates.

Chlamydomonas performs photosynthesis like plants, by converting carbon dioxide, water and the energy of sunlight into oxygen and sugars. Indeed, much of what is known about photosynthesis was learned from Chlamydomonas.

"Now we have learned that we don't know everything about photosynthesis and that there are still many unknown proteins," Merchant said. "We found many proteins involved in antioxidant function. Photosynthesis generates the most powerful oxidants known in biology; there has to be a protection mechanism because oxidation causes aging. In Chlamydomonas, proteins and lipids can get oxidized if reactions of photosynthesis are not properly controlled. We discovered a number of proteins that may be important for protection against oxidative damage."

The scientists identified 349 genes that are present in algae and plants but not in humans and other animals. More than 200 of these genes have unknown functions, a fact that surprises the researchers.

"It's exciting that most of these genes are unknown," Merchant said, adding that the scientists suspect that many of these genes are involved in photosynthesis.

"We don't know what they do yet; we hope to learn what they do," she said.

The scientists identified many new proteins that are likely associated with cilia thin organelles that allow a cell to sense its environment and tell where it is and they differentiated proteins that are critical for movement from those associated with sensory functions. The cilia provide locomotion and act as a cellular antenna.

Humans also have cilia in the brain, lungs and kidneys. The cilia are required for brain function in animals, and for metabolism. The loss of cilia leads to serious diseases, although scientists do not yet know why, Merchant said. Cilia perform key functions for a large number of organs, and the conseque
'/>"/>

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Bioartificial kidney under study at MCG
2. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
3. W.M. Keck Foundation funds study of friendly microbes
4. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
5. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
6. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
7. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
8. Study Links Ebola Outbreaks To Animal Carcasses
9. Genome-wide mouse study yields link to human leukemia
10. Breakthrough Microarray-based Technology for the Study of Cancer
11. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Self-destructing bacteria improve renewable biofuel production 2Self-destructing bacteria improve renewable biofuel production 3IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2Hybrid Concierge Medical Practice Provides More Value Options to Growing Number of Physicians Nationwide 51040 1Hybrid Concierge Medical Practice Provides More Value Options to Growing Number of Physicians Nationwide 51040 2Hybrid Concierge Medical Practice Provides More Value Options to Growing Number of Physicians Nationwide 51040 3The Max Cure Foundation Announces Its First Charity Benefit 3A The Roar for a Cure Carnival to Be Held on Saturday August 22 2009 51038 1The Max Cure Foundation Announces Its First Charity Benefit 3A The Roar for a Cure Carnival to Be Held on Saturday August 22 2009 51038 2The Max Cure Foundation Announces Its First Charity Benefit 3A The Roar for a Cure Carnival to Be Held on Saturday August 22 2009 51038 3The Max Cure Foundation Announces Its First Charity Benefit 3A The Roar for a Cure Carnival to Be Held on Saturday August 22 2009 51038 4The Max Cure Foundation Announces Its First Charity Benefit 3A The Roar for a Cure Carnival to Be Held on Saturday August 22 2009 51038 5Insulet Establishes Eco Friendly Disposal Program for the OmniPod 28R 29 Insulin Management System 51036 1Insulet Establishes Eco Friendly Disposal Program for the OmniPod 28R 29 Insulin Management System 51036 2
Breaking Biology Technology:BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 2BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 3BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 4Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6